The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein
- 7 May 2007
- Vol. 25 (27), 5025-5033
- https://doi.org/10.1016/j.vaccine.2007.04.066
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- The Cytoplasmic Tail of the Human Respiratory Syncytial Virus F Protein Plays Critical Roles in Cellular Localization of the F Protein and Infectious Progeny ProductionJournal of Virology, 2006
- Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus VectorJournal of Virology, 2006
- New Generation Live Vaccines against Human Respiratory Syncytial Virus Designed by Reverse GeneticsProceedings of the American Thoracic Society, 2005
- A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in ratsVaccine, 2004
- Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanismJournal of General Virology, 2004
- trans -Complementation Allows Recovery of Human Respiratory Syncytial Viruses That Are Infectious but Deficient in Cell-to-Cell TransmissionJournal of Virology, 2004
- The Baculovirus GP64 Protein Mediates Highly Stable Infectivity of a Human Respiratory Syncytial Virus Lacking Its Homologous Transmembrane GlycoproteinsJournal of Virology, 2004
- Infectivity of a Human Respiratory Syncytial Virus Lacking the SH, G, and F Proteins Is Efficiently Mediated by the Vesicular Stomatitis Virus G ProteinJournal of Virology, 2003
- Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in InfancyThe Journal of Infectious Diseases, 2000
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979